Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XNW4107 vs Recarbrio for gram-negative HABP/VABP
CTR20222694Phase 3Completed
- Sponsor
- Sinovent
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pibozobactam in hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), sponsored by Sinovent. Started Nov 2022; status: completed.
02
Drugs
pibozobactam
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on CTR20222694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222694.